A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast Cancer

MeSH terms

• Aged
• Animals
• Antineoplastic Agents, Immunological / pharmacology
• Antineoplastic Agents, Immunological / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Bone Neoplasms / diagnostic imaging
• Bone Neoplasms / genetics*
• Bone Neoplasms / secondary
• Bone Neoplasms / therapy
• Breast / diagnostic imaging
• Breast / pathology
• Breast / surgery
• Breast Neoplasms / diagnostic imaging
• Breast Neoplasms / genetics*
• Breast Neoplasms / pathology
• Breast Neoplasms / therapy
• Carcinoma, Ductal, Breast / diagnostic imaging
• Carcinoma, Ductal, Breast / genetics*
• Carcinoma, Ductal, Breast / secondary
• Carcinoma, Ductal, Breast / therapy
• Carcinoma, Intraductal, Noninfiltrating / diagnostic imaging
• Carcinoma, Intraductal, Noninfiltrating / genetics*
• Carcinoma, Intraductal, Noninfiltrating / pathology
• Carcinoma, Intraductal, Noninfiltrating / therapy
• Chemotherapy, Adjuvant / methods
• Drug Resistance, Neoplasm / genetics
• Female
• High-Throughput Nucleotide Sequencing
• Humans
• Liver Neoplasms / diagnostic imaging
• Liver Neoplasms / genetics*
• Liver Neoplasms / secondary
• Liver Neoplasms / therapy
• Mammography
• Mastectomy, Segmental
• Mutation
• Positron Emission Tomography Computed Tomography
• Radiotherapy, Adjuvant
• Receptor, ErbB-2 / genetics*
• Sentinel Lymph Node Biopsy
• Trastuzumab / pharmacology
• Trastuzumab / therapeutic use*
• Treatment Outcome